Alzheimer; News from the web:
No I stick with the saying “when it sounds too good to be trueit usually is….”
But read the post in our link for today andjudge for yourself.
Read all about it HERE
Alzheimer; News from the web:
No I stick with the saying “when it sounds too good to be trueit usually is….”
But read the post in our link for today andjudge for yourself.
Read all about it HERE
Alzheimer; News from the web:
Prof John Hardy said it was likely that drugs will be available by 2025 that will radically push back the age at which people develop dementia.
Read all about it HERE
Alzheimer; News from the web:
Could it be true this time?
Researchers in the U.K. have found that blocking a receptor in the brain that regulates immune cells could “protect against the memory and behavior changes seen in the progression of Alzheimer’s disease.”
According to a news release from the University of Southampton, the research by scientists looking into how Alzheimer’s progresses in the human brain has added to evidence that “inflammation in the brain can in fact drive the development of the disease.”
The study’s findings, published on Friday in the journal Brain, point to the disease potentially being halted if inflammation in the brain is reduced, with hopes of an effective new treatment being developed as a result.
Read all about it HERE
Alzheimer; News from the web:
One small study had earlier talked that this drug could potentially help woman with early stages of Alzheimer’s. A new study however, has now determined that there is no effect at all. The study is small so it will need another larger study to confirm.
Read all about it HERE
Alzheimer; News from the web:
A study done in August suggested that there may be more sorts of Alzheimer’s disease; inflammatory, noninflammatory and cortical.
They would each need different treatment and it may be the reason why lots of drug have failed so far.
Read all about it HERE
Alzheimer; News from the web:
A drug that combines a cough suppressant with a heart medication might offer a safer option for calming the agitation that commonly affects people with Alzheimer’s disease, an early clinical trial suggests.
Read all about it HERE